Literature DB >> 3133701

Steady-state kinetics of doxepin and imipramine in Saudi patients with interethnic comparison.

A el-Yazigi1, K Chaleby.   

Abstract

The pharmacokinetics of doxepin (DX) was studied in 21 Saudi patients treated long term with oral doses of this tricyclic antidepressant agent. The mean (SEM) values of the dose-normalized steady-state concentration and the apparent clearance after oral administration of this drug were 25.8 (4.8) ng.ml-1/mg.kg-1 and 2.529 (0.342) 1.h-1.kg-1, respectively. The pharmacokinetics of imipramine (IMI) was also studied in 30 Saudi patients who received oral doses of this drug for long durations. The mean dose-normalized steady-state concentration of IMI was 68.3 (19.7) ng.ml-1/mg.kg-1, and the mean apparent clearance after oral administration of IMI was 1.619 (0.353) 1.h-1. kg-1. The mean (SEM) ratio of the steady-state concentration of the metabolite desipramine (DES) to that of IMI (DES/IMI) was 0.873 (0.151). Using this value and the ratio of the mean apparent clearance after oral administration (TCL) of DES to that of IMI, the fraction of IMI metabolized to DES was calculated to be 0.489. The TCL of DES was estimated from data obtained for three additional patients who received oral doses of this drug for long durations. A mean value of 0.907 (0.351) 1.h-1.kg-1 was obtained.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133701     DOI: 10.1007/bf00212768

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Differences in the effects of clomipramine on English and Asian volunteers. Preliminary report on a pilot study.

Authors:  J J Allen; P H Rack; K S Vaddadi
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

2.  Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.

Authors:  B Alexanderson
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

Review 3.  Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.

Authors: 
Journal:  Am J Psychiatry       Date:  1985-02       Impact factor: 18.112

4.  Plasma levels and antidepressive effect of imipramine.

Authors:  L F Gram; N Reisby; I Ibsen; A Nagy; S J Dencker; P Bech; G O Petersen; J Christiansen
Journal:  Clin Pharmacol Ther       Date:  1976-03       Impact factor: 6.875

5.  Doxepin plasma concentrations in clinical practice. Could there be a pharmacokinetic explanation for low concentrations?

Authors:  P R Joyce; J R Sharman
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

6.  Multiple-dose doxepin kinetics in depressed patients.

Authors:  R D Faulkner; W M Pitts; C S Lee; W A Lewis; W E Fann
Journal:  Clin Pharmacol Ther       Date:  1983-10       Impact factor: 6.875

7.  Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man.

Authors:  L F Gram; K F Overo
Journal:  Br Med J       Date:  1972-02-19

8.  Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.

Authors:  W Z Potter; A P Zavadil; I J Kopin; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1980-03

Review 9.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

10.  Doxepin kinetics.

Authors:  V E Ziegler; J T Biggs; L T Wylie; S H Rosen; D J Hawf; W H Coryell
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.